Generate Biomedicines, Inc. GENB Gain (Loss), Foreign Currency Transaction, before Tax
Other financials
Where this comes from
Reported directly by Generate Biomedicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossBeforeTax.
The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Generate Biomedicines, Inc. 's gain (loss), foreign currency transaction, before tax.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Generate Biomedicines, Inc. 's gain (loss), foreign currency transaction, before tax?
- Generate Biomedicines, Inc. (GENB) reported gain (loss), foreign currency transaction, before tax of $58K in Q1 2026.